| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.009 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |